Skip to content
Review

Abstract 11510: A Multidisciplinary Resistant Hypertension Clinic Improves Secondary Hypertension Screening and Blood Pressure Control

Nov 2026 · Circulation · 0 citations

Abstract

About 20% of patients with hypertension are resistant. Patients with resistant hypertension are at increased risk for adverse cardiovascular disease. These patients often have a treatable secondary cause and could benefit from a structured referral pathway and specialized clinic to improve screening, optimize treatment, and enhance blood pressure (BP) control. An EMR-based registry was created to identify patients in UC Davis health system with uncontrolled hypertension despite treatment with three or more antihypertensive medications (Figure 1). For eligible patients, primary care physicians received pended referrals and a recommended workup for secondary hypertension. During the initial visit, standardized screening was evaluated including laboratory testing and renal artery ultrasound. Antihypertensive medications were reviewed and adjusted with specialty referrals as clinically indicated. BP was remotely monitored by our team, and medications were adjusted in a timely manner. Select patients were provided a CT angiography to assess their candidacy for advanced renal interventions. Clinical outcomes were measured longitudinally. Of 591 patients with systolic BP above 160mmHg despite being on three or more antihypertensives, 305 referrals were sent after excluding patients with inadequate medication dosages or white-coat hypertension. To date, 138 patients completed their first visit. This cohort included 51 males and 87 females, aged 30-89 years old (68±14 years) (Figure 2A); 47.8% had obstructive sleep apnea (OSA), 34.8% had type II diabetes, and 33% had coronary artery disease. Only about 19.5% of patients had prior evaluation for secondary causes. Concerns for primary hyperaldosteronism were identified in 34% of patients (n= 118) and renal artery stenosis (RAS) was suspected in 20% (n=118) (Figure 2B). Among all patients, 102 patients were found to have at least one underlying etiology: RAS, renal failure, OSA, or primary hyperaldosteronism. Following their initial visit, medication adjustments were implemented in 85 patients. About 41 patients were referred to other specialists, and advanced renal interventions were conducted on 43 patients. Remote BP monitoring program was initiated in 47 patients. Within four months from their initial clinic visit, about 70% (n=119) of patients had BP below 140mmHg. Patient’s mean systolic BP decreased by 12.61mmHg (SD= 23.54) and mean diastolic BP decreased by 4.61mmHg (SD=13.87) (Figure 2B). Resistant hypertension remains underdiagnosed and undertreated despite strong associations with adverse cardiovascular outcomes. By creating a referral process that coordinates structured screening, medication optimization, remote BP monitoring, and specialty referrals, there were significant reductions in patients’ systolic and diastolic BPs.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.